Skip to main content

Table 1 Baseline characteristics (general)

From: Fluvoxamine for fatigue in primary biliary cirrhosis and primary sclerosing cholangitis: a randomised controlled trial [ISRCTN88246634]

  Fluvoxamine N = 17 Placebo N = 16 P-value
Male/Female 4/13 6/10 0.38
PBC/PSC 12/5 10/6 0.57
Age (median) 51 54 0.38
Pruritus (yes/no) 9/8 8/8 0.87
UDCA dose (median, mg/day) 750 900 0.14
Previous depressive disorder (yes/no) (0/17) (1/15) 0.30
Weight (median, kg) 67 71 0.95
Length (median, cm) 173 171 0.67
Body Mass Index (median) 24.2 24.6 0.61
Haemoglobin (mmol/l, median) 8.3 8.8 0.21
Bilirubin (μmol/l, median) 13 11.5 0.83
Alkaline Phosphatase (U/l, median) 137 192 0.36
ALT (U/l, median) 42 43 0.55
Albumin (U/l, median) 42 41.5 0.81
  1. Laboratory reference values: haemoglobin 7.5–9.5 mmol/l, bilirubin 0–16 μmol/l, alkaline phosphatase 0–119 U/l, ALT 0–30 U/l, albumin 35–50 g/l.